Concepts (307)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Homosexuality, Male | 27 | 2023 | 1239 | 4.630 |
Why?
|
Peru | 69 | 2023 | 879 | 3.850 |
Why?
|
Condylomata Acuminata | 5 | 2017 | 82 | 2.220 |
Why?
|
HIV Infections | 46 | 2023 | 16764 | 2.150 |
Why?
|
Tuberculosis | 19 | 2023 | 1892 | 2.010 |
Why?
|
Tuberculosis, Pulmonary | 17 | 2023 | 806 | 1.650 |
Why?
|
Sexual Behavior | 13 | 2021 | 2040 | 1.530 |
Why?
|
Anti-Infective Agents | 7 | 2016 | 973 | 1.340 |
Why?
|
Latent Tuberculosis | 4 | 2023 | 223 | 1.080 |
Why?
|
Therapeutic Irrigation | 3 | 2016 | 300 | 1.030 |
Why?
|
Anus Diseases | 2 | 2015 | 59 | 1.000 |
Why?
|
Universities | 2 | 2021 | 946 | 0.990 |
Why?
|
Ethics, Research | 3 | 2021 | 190 | 0.870 |
Why?
|
Patient Acceptance of Health Care | 8 | 2018 | 3021 | 0.740 |
Why?
|
Tuberculosis, Multidrug-Resistant | 9 | 2020 | 909 | 0.730 |
Why?
|
Research Subjects | 3 | 2019 | 237 | 0.700 |
Why?
|
Problem-Based Learning | 1 | 2022 | 359 | 0.670 |
Why?
|
Lubricants | 4 | 2013 | 31 | 0.660 |
Why?
|
Mycobacterium tuberculosis | 9 | 2021 | 1819 | 0.630 |
Why?
|
Contact Tracing | 9 | 2020 | 273 | 0.620 |
Why?
|
Mental Health Services | 5 | 2020 | 1641 | 0.610 |
Why?
|
Syphilis | 2 | 2017 | 225 | 0.610 |
Why?
|
Genital Neoplasms, Male | 1 | 2017 | 73 | 0.600 |
Why?
|
Papillomavirus Infections | 4 | 2017 | 1585 | 0.600 |
Why?
|
Actigraphy | 1 | 2020 | 488 | 0.570 |
Why?
|
Papillomaviridae | 3 | 2018 | 1117 | 0.560 |
Why?
|
Motivation | 4 | 2019 | 1965 | 0.560 |
Why?
|
Heterosexuality | 2 | 2017 | 272 | 0.540 |
Why?
|
Caregivers | 4 | 2023 | 2067 | 0.530 |
Why?
|
Isoniazid | 5 | 2021 | 271 | 0.520 |
Why?
|
Mouth | 1 | 2018 | 372 | 0.520 |
Why?
|
Sexually Transmitted Diseases | 4 | 2016 | 616 | 0.510 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2020 | 941 | 0.500 |
Why?
|
Antitubercular Agents | 9 | 2021 | 1311 | 0.480 |
Why?
|
HIV Seronegativity | 1 | 2015 | 209 | 0.480 |
Why?
|
Focus Groups | 5 | 2022 | 1308 | 0.470 |
Why?
|
Papillomavirus Vaccines | 2 | 2017 | 490 | 0.470 |
Why?
|
Health Knowledge, Attitudes, Practice | 6 | 2017 | 3908 | 0.460 |
Why?
|
Adolescent | 48 | 2023 | 85405 | 0.440 |
Why?
|
Unsafe Sex | 4 | 2018 | 220 | 0.430 |
Why?
|
Young Adult | 39 | 2023 | 56255 | 0.410 |
Why?
|
Patient Compliance | 2 | 2022 | 2679 | 0.400 |
Why?
|
Condoms | 4 | 2019 | 321 | 0.380 |
Why?
|
Adult | 59 | 2023 | 213394 | 0.380 |
Why?
|
Research | 1 | 2019 | 2001 | 0.380 |
Why?
|
Risk-Taking | 2 | 2015 | 986 | 0.380 |
Why?
|
Family Characteristics | 7 | 2020 | 997 | 0.370 |
Why?
|
Qualitative Research | 5 | 2023 | 2656 | 0.360 |
Why?
|
Rectum | 2 | 2013 | 900 | 0.340 |
Why?
|
Humans | 103 | 2023 | 739398 | 0.340 |
Why?
|
Health Education | 2 | 2015 | 1054 | 0.340 |
Why?
|
Chemoprevention | 1 | 2011 | 323 | 0.330 |
Why?
|
Mental Disorders | 6 | 2020 | 6570 | 0.300 |
Why?
|
Attitude to Health | 3 | 2014 | 2047 | 0.300 |
Why?
|
Male | 64 | 2023 | 349022 | 0.300 |
Why?
|
Administration, Rectal | 4 | 2015 | 73 | 0.300 |
Why?
|
Pyrazinamide | 2 | 2017 | 54 | 0.290 |
Why?
|
Depression | 3 | 2023 | 7689 | 0.290 |
Why?
|
Anti-HIV Agents | 2 | 2023 | 4320 | 0.280 |
Why?
|
Healthcare Disparities | 2 | 2022 | 3138 | 0.280 |
Why?
|
BCG Vaccine | 4 | 2018 | 362 | 0.280 |
Why?
|
Social Stigma | 4 | 2022 | 695 | 0.280 |
Why?
|
California | 2 | 2021 | 1400 | 0.270 |
Why?
|
Female | 54 | 2023 | 378853 | 0.270 |
Why?
|
Family Practice | 1 | 2008 | 516 | 0.260 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2017 | 2012 | 0.260 |
Why?
|
Substance-Related Disorders | 4 | 2020 | 4239 | 0.260 |
Why?
|
Peer Group | 4 | 2020 | 635 | 0.260 |
Why?
|
Social Environment | 2 | 2019 | 1014 | 0.250 |
Why?
|
Mass Screening | 8 | 2022 | 5265 | 0.250 |
Why?
|
Anal Canal | 2 | 2018 | 373 | 0.250 |
Why?
|
Sleep | 1 | 2020 | 4596 | 0.240 |
Why?
|
Ecuador | 2 | 2014 | 55 | 0.240 |
Why?
|
Exercise | 1 | 2020 | 5591 | 0.230 |
Why?
|
Medication Adherence | 4 | 2023 | 2047 | 0.230 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 3051 | 0.230 |
Why?
|
Sexual Partners | 3 | 2017 | 727 | 0.220 |
Why?
|
Prospective Studies | 18 | 2022 | 53037 | 0.210 |
Why?
|
Cross-Sectional Studies | 10 | 2023 | 24714 | 0.200 |
Why?
|
Communicable Disease Control | 3 | 2021 | 853 | 0.200 |
Why?
|
Prevalence | 11 | 2020 | 15153 | 0.190 |
Why?
|
Weights and Measures | 1 | 2020 | 43 | 0.190 |
Why?
|
Patient Participation | 3 | 2022 | 1441 | 0.190 |
Why?
|
Sociobiology | 1 | 2019 | 1 | 0.180 |
Why?
|
HIV | 3 | 2018 | 1607 | 0.180 |
Why?
|
Self Disclosure | 2 | 2019 | 251 | 0.180 |
Why?
|
Faculty | 1 | 2022 | 376 | 0.170 |
Why?
|
Capacity Building | 2 | 2018 | 246 | 0.170 |
Why?
|
HIV Long-Term Survivors | 1 | 2019 | 126 | 0.170 |
Why?
|
Urban Population | 2 | 2020 | 2014 | 0.160 |
Why?
|
Vitamin E Deficiency | 1 | 2018 | 33 | 0.160 |
Why?
|
Genitalia | 1 | 2018 | 111 | 0.160 |
Why?
|
Child | 18 | 2023 | 77033 | 0.160 |
Why?
|
Tuberculosis Vaccines | 1 | 2017 | 48 | 0.150 |
Why?
|
Stereotyping | 1 | 2019 | 240 | 0.150 |
Why?
|
Interviews as Topic | 3 | 2014 | 2533 | 0.150 |
Why?
|
Vitamin A Deficiency | 1 | 2017 | 101 | 0.150 |
Why?
|
Health Services Accessibility | 4 | 2022 | 5128 | 0.150 |
Why?
|
Socioeconomic Factors | 4 | 2022 | 7726 | 0.150 |
Why?
|
Health Facilities | 1 | 2022 | 564 | 0.150 |
Why?
|
Interpersonal Relations | 4 | 2019 | 1421 | 0.140 |
Why?
|
Latin America | 1 | 2018 | 380 | 0.140 |
Why?
|
Ethics Committees, Research | 1 | 2018 | 194 | 0.140 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2018 | 230 | 0.140 |
Why?
|
Ethambutol | 1 | 2016 | 62 | 0.140 |
Why?
|
Delivery of Health Care | 3 | 2021 | 5272 | 0.140 |
Why?
|
Incidence | 10 | 2019 | 20913 | 0.140 |
Why?
|
Sputum | 4 | 2021 | 474 | 0.140 |
Why?
|
Homosexuality | 2 | 2015 | 265 | 0.140 |
Why?
|
Amidohydrolases | 1 | 2016 | 171 | 0.130 |
Why?
|
Financing, Personal | 1 | 2018 | 310 | 0.130 |
Why?
|
Risk Factors | 14 | 2023 | 71974 | 0.130 |
Why?
|
Pregnant Women | 1 | 2020 | 558 | 0.130 |
Why?
|
Crime Victims | 1 | 2019 | 321 | 0.130 |
Why?
|
Depressive Disorder | 1 | 2008 | 3743 | 0.130 |
Why?
|
Selection, Genetic | 1 | 2020 | 915 | 0.130 |
Why?
|
Odds Ratio | 3 | 2023 | 9846 | 0.130 |
Why?
|
Safe Sex | 1 | 2015 | 140 | 0.130 |
Why?
|
Gender Identity | 2 | 2023 | 674 | 0.130 |
Why?
|
Middle Aged | 32 | 2022 | 212863 | 0.130 |
Why?
|
Child, Preschool | 11 | 2022 | 40802 | 0.120 |
Why?
|
Influenza Vaccines | 1 | 2022 | 740 | 0.120 |
Why?
|
Social Support | 3 | 2022 | 2112 | 0.120 |
Why?
|
Uganda | 1 | 2019 | 1230 | 0.120 |
Why?
|
Genome, Bacterial | 1 | 2019 | 756 | 0.120 |
Why?
|
Health Care Reform | 3 | 2018 | 1258 | 0.120 |
Why?
|
Cannabis | 1 | 2020 | 430 | 0.120 |
Why?
|
Treponema pallidum | 1 | 2013 | 40 | 0.120 |
Why?
|
Anus Neoplasms | 1 | 2017 | 329 | 0.120 |
Why?
|
Brazil | 1 | 2018 | 1264 | 0.120 |
Why?
|
Body Height | 1 | 2020 | 1577 | 0.120 |
Why?
|
Perception | 1 | 2020 | 1177 | 0.110 |
Why?
|
Chlamydia Infections | 2 | 2016 | 364 | 0.110 |
Why?
|
Vitamin E | 1 | 2018 | 870 | 0.110 |
Why?
|
Pharynx | 1 | 2016 | 411 | 0.110 |
Why?
|
Molecular Epidemiology | 1 | 2015 | 469 | 0.110 |
Why?
|
Pilot Projects | 3 | 2022 | 8275 | 0.110 |
Why?
|
Learning | 1 | 2022 | 1695 | 0.110 |
Why?
|
Primary Prevention | 1 | 2020 | 1165 | 0.110 |
Why?
|
Cohort Studies | 9 | 2020 | 40389 | 0.110 |
Why?
|
Health Promotion | 2 | 2015 | 2187 | 0.110 |
Why?
|
Health Personnel | 3 | 2022 | 3203 | 0.110 |
Why?
|
Students | 1 | 2022 | 1637 | 0.110 |
Why?
|
Gonorrhea | 2 | 2016 | 335 | 0.110 |
Why?
|
Feasibility Studies | 2 | 2020 | 5058 | 0.110 |
Why?
|
South America | 1 | 2012 | 181 | 0.110 |
Why?
|
Genetic Heterogeneity | 1 | 2016 | 727 | 0.100 |
Why?
|
Transvestism | 1 | 2011 | 5 | 0.100 |
Why?
|
Mental Health | 2 | 2023 | 2946 | 0.100 |
Why?
|
Marketing of Health Services | 1 | 2012 | 153 | 0.100 |
Why?
|
Primary Health Care | 2 | 2018 | 4537 | 0.100 |
Why?
|
Public Health | 2 | 2022 | 2587 | 0.100 |
Why?
|
Influenza, Human | 1 | 2022 | 1476 | 0.100 |
Why?
|
Mutation, Missense | 1 | 2020 | 2552 | 0.090 |
Why?
|
Terminology as Topic | 1 | 2018 | 1548 | 0.090 |
Why?
|
Disease Progression | 4 | 2019 | 13237 | 0.090 |
Why?
|
Logistic Models | 4 | 2022 | 13402 | 0.090 |
Why?
|
Anti-Infective Agents, Local | 1 | 2012 | 248 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2016 | 840 | 0.090 |
Why?
|
Drug Costs | 1 | 2018 | 1115 | 0.090 |
Why?
|
Age Factors | 9 | 2020 | 18349 | 0.090 |
Why?
|
Vitamin D Deficiency | 1 | 2019 | 1327 | 0.090 |
Why?
|
Infant | 10 | 2020 | 34923 | 0.080 |
Why?
|
Anxiety Disorders | 1 | 2020 | 2674 | 0.080 |
Why?
|
Victoria | 1 | 2008 | 66 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2028 | 0.080 |
Why?
|
Tobacco Smoke Pollution | 1 | 2014 | 814 | 0.080 |
Why?
|
Nutritional Status | 1 | 2016 | 1587 | 0.080 |
Why?
|
Residence Characteristics | 3 | 2022 | 2041 | 0.080 |
Why?
|
Anti-Retroviral Agents | 2 | 2019 | 1734 | 0.080 |
Why?
|
Health Behavior | 1 | 2019 | 2624 | 0.080 |
Why?
|
Rifampin | 2 | 2019 | 314 | 0.080 |
Why?
|
Emotions | 2 | 2018 | 2642 | 0.080 |
Why?
|
Family | 1 | 2018 | 3141 | 0.070 |
Why?
|
Tuberculin Test | 2 | 2019 | 211 | 0.070 |
Why?
|
Alcohol Drinking | 2 | 2016 | 3945 | 0.070 |
Why?
|
Counseling | 3 | 2023 | 1526 | 0.070 |
Why?
|
Vitamin D | 1 | 2019 | 3197 | 0.070 |
Why?
|
Factor Analysis, Statistical | 1 | 2008 | 976 | 0.070 |
Why?
|
Human Rights | 1 | 2008 | 303 | 0.070 |
Why?
|
Biomedical Research | 2 | 2018 | 3301 | 0.060 |
Why?
|
Risk | 2 | 2017 | 9684 | 0.060 |
Why?
|
Pregnancy | 3 | 2023 | 29002 | 0.060 |
Why?
|
Research Design | 1 | 2021 | 5959 | 0.060 |
Why?
|
Public Policy | 1 | 2008 | 570 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2021 | 14740 | 0.060 |
Why?
|
Asthma | 1 | 2022 | 5950 | 0.060 |
Why?
|
Internet | 1 | 2015 | 3048 | 0.050 |
Why?
|
Disease Transmission, Infectious | 2 | 2016 | 554 | 0.050 |
Why?
|
Microbial Sensitivity Tests | 2 | 2019 | 1866 | 0.050 |
Why?
|
Nepal | 1 | 2023 | 289 | 0.050 |
Why?
|
Infant, Newborn | 5 | 2020 | 25470 | 0.050 |
Why?
|
Physicians | 1 | 2020 | 4539 | 0.050 |
Why?
|
Patient-Centered Care | 2 | 2022 | 1435 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2023 | 76631 | 0.050 |
Why?
|
Models, Statistical | 2 | 2014 | 5113 | 0.050 |
Why?
|
Microfibrils | 1 | 2020 | 17 | 0.050 |
Why?
|
Indians, South American | 1 | 2020 | 36 | 0.050 |
Why?
|
Truth Disclosure | 1 | 2004 | 437 | 0.050 |
Why?
|
X-Rays | 1 | 2021 | 300 | 0.050 |
Why?
|
Aged | 11 | 2022 | 162698 | 0.050 |
Why?
|
Treatment Outcome | 6 | 2023 | 62693 | 0.040 |
Why?
|
Heredity | 1 | 2020 | 153 | 0.040 |
Why?
|
Epidemics | 2 | 2017 | 520 | 0.040 |
Why?
|
Genotype | 3 | 2019 | 12951 | 0.040 |
Why?
|
Body Mass Index | 1 | 2016 | 12655 | 0.040 |
Why?
|
Bacterial Typing Techniques | 1 | 2019 | 256 | 0.040 |
Why?
|
Self Efficacy | 1 | 2022 | 607 | 0.040 |
Why?
|
Self-Help Groups | 1 | 2019 | 188 | 0.040 |
Why?
|
Pandemics | 3 | 2023 | 8274 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12237 | 0.040 |
Why?
|
Viral Load | 2 | 2023 | 3299 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2008 | 6028 | 0.040 |
Why?
|
Health Services | 1 | 2023 | 757 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2019 | 13880 | 0.040 |
Why?
|
Smoking | 1 | 2014 | 8960 | 0.040 |
Why?
|
National Health Programs | 1 | 2021 | 445 | 0.040 |
Why?
|
Haiti | 1 | 2019 | 550 | 0.040 |
Why?
|
Treatment Failure | 1 | 2023 | 2614 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2020 | 429 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2017 | 7897 | 0.040 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 495 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2017 | 19811 | 0.040 |
Why?
|
Sequence Analysis, DNA | 2 | 2019 | 4791 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2019 | 21694 | 0.030 |
Why?
|
Sex Factors | 3 | 2020 | 10398 | 0.030 |
Why?
|
Health Policy | 2 | 2018 | 2655 | 0.030 |
Why?
|
Health Educators | 1 | 2015 | 20 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2019 | 57650 | 0.030 |
Why?
|
Sex Offenses | 1 | 2019 | 347 | 0.030 |
Why?
|
Gene Expression | 2 | 2019 | 7788 | 0.030 |
Why?
|
Rural Health Services | 1 | 2018 | 378 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2021 | 1453 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 20676 | 0.030 |
Why?
|
World Health Organization | 1 | 2020 | 1321 | 0.030 |
Why?
|
Patient Selection | 1 | 2007 | 4211 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2019 | 38942 | 0.030 |
Why?
|
Social Facilitation | 1 | 1994 | 31 | 0.030 |
Why?
|
Carotenoids | 1 | 2017 | 624 | 0.030 |
Why?
|
Vitamin A | 1 | 2017 | 613 | 0.030 |
Why?
|
Chlamydia trachomatis | 1 | 2016 | 246 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2019 | 1467 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2020 | 6370 | 0.030 |
Why?
|
Aging | 2 | 2023 | 8613 | 0.030 |
Why?
|
Biological Assay | 1 | 2016 | 653 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2014 | 516 | 0.030 |
Why?
|
Neisseria gonorrhoeae | 1 | 2016 | 238 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3585 | 0.030 |
Why?
|
Quality Improvement | 2 | 2018 | 3730 | 0.030 |
Why?
|
Technology | 1 | 2015 | 299 | 0.030 |
Why?
|
Rural Population | 1 | 2022 | 2181 | 0.030 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2016 | 563 | 0.030 |
Why?
|
Data Collection | 2 | 2012 | 3341 | 0.030 |
Why?
|
Washington | 2 | 2004 | 314 | 0.030 |
Why?
|
Self Report | 1 | 2023 | 3524 | 0.030 |
Why?
|
Mutation | 1 | 2016 | 29658 | 0.030 |
Why?
|
Executive Function | 1 | 2020 | 1356 | 0.020 |
Why?
|
Mammography | 1 | 2022 | 2466 | 0.020 |
Why?
|
Adolescent Behavior | 1 | 2019 | 1146 | 0.020 |
Why?
|
Sentinel Surveillance | 1 | 2013 | 291 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2020 | 12178 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2017 | 2711 | 0.020 |
Why?
|
South Africa | 1 | 2016 | 1743 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6478 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2012 | 1676 | 0.020 |
Why?
|
Biopsy | 1 | 2022 | 6722 | 0.020 |
Why?
|
Communication | 2 | 2022 | 3722 | 0.020 |
Why?
|
Monocytes | 1 | 2019 | 2583 | 0.020 |
Why?
|
China | 1 | 2016 | 2225 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2017 | 1031 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3232 | 0.020 |
Why?
|
Genetic Loci | 1 | 2019 | 2567 | 0.020 |
Why?
|
Mentors | 1 | 2015 | 632 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 2017 | 1054 | 0.020 |
Why?
|
Program Evaluation | 2 | 2015 | 2484 | 0.020 |
Why?
|
Empathy | 1 | 1994 | 471 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2124 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2016 | 1123 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6516 | 0.020 |
Why?
|
Risk Assessment | 2 | 2020 | 23294 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2015 | 928 | 0.020 |
Why?
|
Educational Status | 1 | 2015 | 2514 | 0.020 |
Why?
|
Computers | 1 | 2010 | 614 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2013 | 2602 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10247 | 0.020 |
Why?
|
HIV Seropositivity | 1 | 2012 | 966 | 0.020 |
Why?
|
Anthropology, Cultural | 1 | 2007 | 96 | 0.020 |
Why?
|
Teaching | 1 | 1994 | 1166 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12328 | 0.020 |
Why?
|
Administration, Oral | 1 | 2013 | 3909 | 0.020 |
Why?
|
Los Angeles | 1 | 2004 | 236 | 0.020 |
Why?
|
Sample Size | 1 | 2007 | 845 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5652 | 0.010 |
Why?
|
Cognition | 1 | 2020 | 6686 | 0.010 |
Why?
|
Genetic Variation | 1 | 2017 | 6539 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7274 | 0.010 |
Why?
|
Social Responsibility | 1 | 2004 | 384 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3609 | 0.010 |
Why?
|
Urethritis | 1 | 2000 | 22 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15500 | 0.010 |
Why?
|
Fear | 1 | 2004 | 1430 | 0.010 |
Why?
|
HIV-1 | 1 | 2013 | 6931 | 0.010 |
Why?
|
United States | 1 | 2023 | 69573 | 0.010 |
Why?
|
Brain | 1 | 2020 | 26345 | 0.010 |
Why?
|
Human Development | 1 | 1994 | 124 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 40050 | 0.010 |
Why?
|
Curriculum | 1 | 1994 | 3575 | 0.000 |
Why?
|
Concepts
(307)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(37)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_